Food and Drug Administration regulatory agency in the united states determines the acceptable daily intake (adi) guidelines for alternative sweeteners.
The Food and Drug Administration (FDA) is in charge of safeguarding the public's health by ensuring the security, safety, and efficacy of biological goods, medical devices, our country's food supply, cosmetics, and radiation-emitting products. The public can obtain reliable health information from the FDA that is supported by science.
The Federal Food, Drug, and Cosmetic Act (FD&C) is the FDA's main area of enforcement, although the organization also upholds other laws, most notably Section 361 of the Public Health Service Act, as well as related regulations. A large portion of this regulatory enforcement effort covers both the prevention and control of disease as well as the regulation of lasers, cell phones, and other items that are not immediately related to food or medications.
Learn more about Drug administration here:
brainly.com/question/2026177
#SPJ4
Answer: Because the healthcare revenue cycle process is important and includes includes coding medical services and billing insurance. Making sure that patients have eligible insurance on file can help in determining costs for various treatments. Faster and more accurate claims transmission allows for greater flexibility in arranging patient care.
Explanation:
Answer: A
Explanation:
The priority is to decrease oxygen consumption by sitting this client down. When the client's condition is stabilized, he can be returned to bed. An ECG can be obtained after the client is sitting down, and the ordered sublingual nitroglycerin could be administered.
Answer:
H90.3
Explanation:
Sensorineural Hearing Loss is one of the type of the hearing loss. Root cause of this hearing loss lies in inner ear or the sensory organ or vestibulocochlear nerve.
It accounts for approximately 90% of the reported hearing loss.
It is permanent generally and can be mild to moderate to severe.
<u>H90.3 is specific/billable ICD-10-CM code which is used to indicate the diagnosis for the reimbursement purposes.
</u>
<u>On October 1 2018,2019 edition of ICD-10-CM H90.3 became effective.</u>
Answer:
D.Partial hospitalization/day treatment
Explanation:
hope it helps♡´･ᴗ･`♡
